Table 3.
Secondary prevention measures in 2783 women and 3108 men with ischaemic heart disease
| Variable | No (%) of women | No (%) of men | P value (χ2 test) |
|---|---|---|---|
| Fasting serum cholesterol recorded: | 968 (35) | 1550 (50) | <0.0001 |
| Maximum level >5 mmol/1 | 749 (77) | 1043 (67) | <0.0001 |
| Most recent level >5 mmol/l | 809 (84) | 928 (60) | <0.0001 |
| Recorded diagnosis of hyperlipidaemia | 274 (10) | 418 (13) | <0.0001 |
| Lipid lowering treatment | 596 (21) | 973 (31) | <0.0001 |
| Aspirin | 1979 (71) | 2358 (76) | <0.0001 |
| Recorded contraindication to aspirin | 602 (22) | 642 (21) | 0.36 |
| β blocker | 1369 (49) | 1589 (51) | 0.14 |